You are here

Department of Pulmonology

Department of Pulmonology

Name: Department of Pulmonology

Publication list

Uploaded publications:
338
Publications in DEA:
336
OA:
54
Date range:
1975-2023
2023
  1. Tornyi, I., Árkosy, P., Horváth, I., Furka, A.: A new perspective on the proper timing of radiotherapy during CDK4/6 inhibitor therapy in patients with "bone-only" metastatic breast cancer.
    Pathol. Oncol. Res. 29 1-8, 2023.
    Journal metrics:
    Q3 Cancer Research (2022)
    Q2 Medicine (miscellaneous) (2022)
    Q3 Oncology (2022)
    Q2 Pathology and Forensic Medicine (2022)
  2. Tornyi, I., Lázár, J., Pettkó-Szandtner, A., Hunyadi-Gulyás, É., Takács, L.: Epitomics: Analysis of Plasma C9 Epitope Heterogeneity in the Plasma of Lung Cancer Patients and Control Subjects.
    Int. J. Mol. Sci. 24 (18), 1-13, 2023.
    Journal metrics:
    Q2 Catalysis (2022)
    Q1 Computer Science Applications (2022)
    D1 Inorganic Chemistry (2022)
    Q1 Medicine (miscellaneous) (2022)
    Q2 Molecular Biology (2022)
    Q1 Organic Chemistry (2022)
    Q1 Physical and Theoretical Chemistry (2022)
    D1 Spectroscopy (2022)
  3. Kiss, H., Örlős, Z., Gellért, Á., Megyesfalvi, Z., Mikáczó, A., Sárközi, A., Vaskó, A., Miklós, Z., Horváth, I.: Exhaled Biomarkers for Point-of-Care Diagnosis: Recent Advances and New Challenges in Breathomics.
    Micromachines. 14 (2), 1-29, 2023.
    Journal metrics:
    Q2 Control and Systems Engineering (2022)
    Q2 Electrical and Electronic Engineering (2022)
    Q2 Mechanical Engineering (2022)
  4. Kerpel-Fronius, A., Megyesfalvi, Z., Markóczy, Z., Székely, A., Vaskó, A.: HUNCHEST-II contributes to a shift to earlier-stage lung cancer detection: final results of a nationwide screening program.
    Eur Radiol. [Epub ahead of print]2023.
  5. Sebestyén, E., Major, N., Bodoki, L., Makai, A., Balogh, I., Tóth, G., Orosz, Z., Árkosy, P., Vaskó, A., Hódosi, K., Szekanecz, Z., Szekanecz, É., Hungarian OncoRheumatology Network (HORN) initiative: Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience.
    Front Oncol. 13 1-9, 2023.
    Journal metrics:
    Q2 Cancer Research (2022)
    Q2 Oncology (2022)
  6. Lázár, J., Antal-Szalmás, P., Kurucz, I., Ferenczi, A., Józsi, M., Tornyi, I., Müller, M., Fekete, J., Lamont, J., FitzGerald, P., Gall-Debreceni, A., Kádas, J., Vida, A., Tardieu, N., Kieffer, Y., Jullien, A., Guergova-Kuras, M., Hempel, W., Kovács, A., Kardos, T., Bittner, N., Csánky, E., Szilasi, M., Losonczy, G., Szondy, K., Gálffy, G., Csada, E., Szalontai, K., Somfay, A., Malka, D., Cottu, P., Bogos, K., Takács, L.: Large-scale plasma proteome epitome profiling is an efficient tool for the discovery of cancer biomarkers.
    Mol. Cell. Proteomics. 22 (7), 1-18, 2023.
    Journal metrics:
    D1 Analytical Chemistry (2022)
    D1 Biochemistry (2022)
    D1 Medicine (miscellaneous) (2022)
    Q1 Molecular Biology (2022)
  7. László, I., Berhés, M., Tisza, K., Miltényi, Z., Balázsfalvi, N., Vaskó, A., Asztalos, L., Kertész, A., Fábián, Á., Kappelmayer, J., Fülesdi, B.: The prognostic value of laboratory parameters referring to hemopoietic stress in patients with COVID-19: a single center experience.
    Signa Vitae. 19 (3), 36-43, 2023.
    Journal metrics:
    Q3 Critical Care and Intensive Care Medicine (2022)
    Q3 Emergency Medicine (2022)
  8. Miklós, Z., Horváth, I.: The Role of Oxidative Stress and Antioxidants in Cardiovascular Comorbidities in COPD.
    Antioxidants. 12 (6), 1-29, 2023.
    Journal metrics:
    Q1 Biochemistry (2022)
    Q2 Cell Biology (2022)
    Q1 Clinical Biochemistry (2022)
    D1 Food Science (2022)
    Q2 Molecular Biology (2022)
    Q1 Physiology (2022)
2022
  1. Méhes, G., Mokánszki, A., Tóth, L., Csoma, S., Lieber, A., Bittner, N.: Malignant pleural effusions for cancer genotyping: a matter of trans-pleural traffic of cell-free tumor DNA.
    Mol. Cell. Probes. 61 1-7, 2022.
    Journal metrics:
    Q3 Cell Biology
    Q3 Molecular Biology
  2. Hochmair, M., Kolb, R., Wurm, R., Zach, H., Bittner, N.: Nintedanib plus Docetaxel after Immune Checkpoint Inhibitor Failure in Patients with Advanced Non-Small-Cell Lung Cancer: a Case Series.
    Case Rep Oncol. 15 138-148, 2022.
    Journal metrics:
    Q4 Oncology
  3. Kiss, Z., Bogos, K., Tamási, L., Ostoros, G., Müller, V., Bittner, N., Sárosi, V., Vastag, A., Knollmajer, K., Várnai, M., Kovács, K., Berta, A., Köveskuti, I., Karamousouli, E., Rokszin, G., Abonyi-Tóth, Z., Barcza, Z., Kenessey, I., Wéber, A., Nagy, P., Freyler-Fadgyas, P., Szócska, M., Szegner, P., Hilbert, L., Branyiczkiné Géczy, G., Surján, G., Moldvay, J., Vokó, Z., Gálffy, G., Polányi, Z.: Underlying reasons for post-mortem diagnosed lung cancer cases: A robust retrospective comparative study from Hungary (HULC study).
    Front Oncol. 12 1-11, 2022.
    Journal metrics:
    Q2 Cancer Research
    Q2 Oncology
2021
  1. Orosz, Z.: A COVID-fertőzés hosszú távú tüdőszövődményei.
    Orvostovábbk. szle. 2 (2), 15-20, 2021.
  2. Tamási, L., Horváth, K., Kiss, Z., Bogos, K., Ostoros, G., Müller, V., Urbán, L., Bittner, N., Sárosi, V., Vastag, A., Polányi, Z., Nagy-Erdei, Z., Daniel, A., Nagy, B., Rokszin, G., Abonyi-Tóth, Z., Moldvay, J., Vokó, Z., Gálffy, G.: Age and Gender Specific Lung Cancer Incidence and Mortality in Hungary: trends from 2011 Through 2016.
    Pathol. Oncol. Res. 27 1-9, 2021.
    Journal metrics:
    Q3 Cancer Research
    Q2 Medicine (miscellaneous)
    Q3 Oncology
    Q2 Pathology and Forensic Medicine
  3. Bogos, K., Gálffy, G., Kiss, Z., Tamási, L., Ostoros, G., Müller, V., Urbán, L., Bittner, N., Sárosi, V., Vastag, A., Polányi, Z., Daniel, A., Nagy, B., Rokszin, G., Abonyi-Tóth, Z., Barcza, Z., Moldvay, J., Vokó, Z.: Analysis of lung cancer patient pathway: a 6-year nationwide analysis from Hungary.
    J. Thorac. Oncol. 16 (4), S718, 2021.
  4. Opposits, G., Nagy, M., Barta, Z., Aranyi, S., Szabó, D., Makai, A., Varga, I., Galuska, L., Trón, L., Balkay, L., Emri, M.: Automated procedure assessing the accuracy of HRCT-PET registration applied in functional virtual bronchoscopy.
    EJNMMI Res. 11 (1), 1-13, 2021.
    Journal metrics:
    Q2 Radiology, Nuclear Medicine and Imaging
  5. Mokánszki, A., Bádon, E., Mónus, A., Tóth, L., Bittner, N., Méhes, G.: Cell-free DNA From Pleural Effusion Samples: is It Right for Molecular Testing in Lung Adenocarcinoma?.
    Pathol. Oncol. Res. 27 1-7, 2021.
    Journal metrics:
    Q3 Cancer Research
    Q2 Medicine (miscellaneous)
    Q3 Oncology
    Q2 Pathology and Forensic Medicine
  6. Kiss, Z., Bogos, K., Tamási, L., Ostoros, G., Müller, V., Urbán, L., Bittner, N., Sárosi, V., Vastag, A., Polányi, Z., Nagy-Erdei, Z., Knollmajer, K., Várnai, M., Nagy, B., Horváth, K., Rokszin, G., Abonyi-Tóth, Z., Barcza, Z., Moldvay, J., Gálffy, G., Vokó, Z.: Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary.
    Pathol. Oncol. Res. 27 1-11, 2021.
    Journal metrics:
    Q3 Cancer Research
    Q2 Medicine (miscellaneous)
    Q3 Oncology
    Q2 Pathology and Forensic Medicine
2020
  1. Vaskó, A., Bittner, N.: A D-vitamin és a COPD exacerbációja.
    Orvostovábbk. Szle. 26 (12), 47-50, 2020.
  2. Szekanecz, Z., Gomez, I., Soós, B., Bodoki, L., Szamosi, S., András, C., Juhász, B., Váróczy, L., Antal-Szalmás, P., Szodoray, P., Bittner, N., Árkosy, P., Illés, Á., Szűcs, G., Dankó, K., Bender, T., Tamási, L., Szekanecz, É., Hungarian OncoRheumatology Network (HORN) initiative: Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases.
    Autoimmun. Rev. 19 (11), 1-12, 2020.
    Journal metrics:
    Q1 Immunology
    Q1 Immunology and Allergy
Show all
updated: 2024-03-17, 02:53

SCImago quartiles of
scientific journal articles

Number of scientific articles: 223
Q1/D1 17 (7.6%)
Q1 41 (18.4%)
Q2 27 (12.1%)
Q3 15 (6.7%)
Q4 7 (3.1%)
N/A 133 (59.6%)
-
OK

SCImago subject areas and categories

Medicine (73)
Medicine (miscellaneous) (44)
Oncology (15)
Pulmonary and Respiratory Medicine (13)
Immunology and Allergy (6)
Pharmacology (medical) (6)
Microbiology (medical) (5)
Pathology and Forensic Medicine (5)
Infectious Diseases (3)
Public Health, Environmental and Occupational Health (3)
Critical Care and Intensive Care Medicine (2)
Emergency Medicine (2)
Health Policy (2)
Hematology (2)
Physiology (medical) (2)
Radiology, Nuclear Medicine and Imaging (2)
Biochemistry (medical) (1)
Cardiology and Cardiovascular Medicine (1)
Genetics (clinical) (1)
Neurology (clinical) (1)
Obstetrics and Gynecology (1)
Pediatrics, Perinatology and Child Health (1)
Reproductive Medicine (1)
Biochemistry, Genetics and Molecular Biology (28)
Cancer Research (10)
Molecular Biology (9)
Biochemistry (8)
Clinical Biochemistry (5)
Cell Biology (4)
Physiology (3)
Biophysics (2)
Biochemistry, Genetics and Molecular Biology (miscellaneous) (1)
Biotechnology (1)
Genetics (1)
Molecular Medicine (1)
Pharmacology, Toxicology and Pharmaceutics (11)
Pharmacology (5)
Pharmaceutical Science (3)
Toxicology (3)
Drug Discovery (1)
Immunology and Microbiology (10)
Immunology (7)
Microbiology (3)
Applied Microbiology and Biotechnology (2)
Agricultural and Biological Sciences (7)
Agronomy and Crop Science (3)
Plant Science (3)
Ecology, Evolution, Behavior and Systematics (2)
Food Science (2)
Agricultural and Biological Sciences (miscellaneous) (1)
Aquatic Science (1)
Chemistry (6)
Analytical Chemistry (4)
Inorganic Chemistry (2)
Organic Chemistry (2)
Physical and Theoretical Chemistry (2)
Spectroscopy (2)
Chemical Engineering (3)
Catalysis (2)
Bioengineering (1)
Engineering (3)
Biomedical Engineering (2)
Control and Systems Engineering (1)
Electrical and Electronic Engineering (1)
Mechanical Engineering (1)
Environmental Science (3)
Ecology (1)
Health, Toxicology and Mutagenesis (1)
Pollution (1)
Computer Science (2)
Computer Science Applications (2)
Materials Science (2)
Biomaterials (1)
Nanoscience and Nanotechnology (1)
Neuroscience (2)
Neurology (1)
Neuroscience (miscellaneous) (1)
Veterinary (2)
Veterinary (miscellaneous) (2)

Genre chart

Year chart

Language chart

Journals

Show more